Quick Takeaways: Why It Matters? The Neion Bio–Barnwell Bio partnership highlights how environmental biosurveillance can strengthen biosecurity in biologics manufacturing, where flock health directly affects production continuity. By detecting facility-level pathoge...
Quick Takeaways: Why It Matters? BiomEdit’s USDA conditional licensure for CPerf LLV (to be branded Optavant) creates the first genetically engineered probiotic biologic for poultry, offering a non‑antibiotic tool against necrotic enteritis-a disease costing the global broiler ...
Quick Takeaways: Why It Matters? Alveo Technologies and Royal GD are deepening a three‑year partnership (with 18 months of commercial use of their on‑farm avian influenza test) to co‑develop rapid molecular assays on the Alveo Sense platform for additional swine and cattle path...
Quick Takeaways: Why It Matters? ECO Animal Health’s acceptance of field safety data for Ecovaxxin MS by the USDA‑CVB is a key regulatory step toward US licensure of its Mycoplasma synoviae poultry vaccine, following the product’s EU commercial launch in July 2026. The large fi...
Featured Article Cover Story Product Launch Partnership Research Updates Regulatory Updates Bond Vet and Small Door Veterinary Complete Merger Corporate transaction Bond Vet and Small Door Veterinary have completed their merger, creating one of the largest premium veterinary care networks ...
Quick Takeaways: Why It Matters? Zoetis’ EC approval of Poulvac Procerta HVT-ND turns its single-dose, dual ND+Marek’s protection into a mainstream EU option, which should drive rapid adoption as producers shift from multi-vaccine schedules to a streamlined, in‑ovo or hatch-day protocol th...
Featured Article Cover Story Regulatory Updates Launch Product Launch PetMeds Receives New Acquisition Proposal Corporate transaction PetMed Express has received an unsolicited, non-binding proposal from SilverCape Investments to acquire all outstanding shares for $3.00 per share in cash. ...
Quick Takeaways: Why It Matters? ECO Animal Health’s EU launch of Ecovaxxin MS is a meaningful commercial milestone because it converts the company’s own R&D pipeline into a marketed product and gives it a differentiated position in poultry vaccines. With access to a market spanning mo...
The US FDA’s 2025 animal health approvals highlight a transformative year for veterinary medicine, with major advances spanning companion animal therapeutics, livestock productivity, poultry health, parasitic disease management, diagnostics, oncology, and genetic innovation. The latest wav...
Featured Article Cover Story Research & Innovation Financing & Partnerships Product Launches Mergers & Acquisitions Regulatory Updates At a Glance Merck Animal Health Expands Poultry Tech Portfolio Acquisition Merck Animal Health has agreed to acquire TARGAN, adding advanced po...
